Results 21 to 30 of about 5,655,373 (303)

Non-alcoholic fatty liver disease: a global concern

open access: yes, 2022
Liver disease is a worldwide issue with death rates exponentially increasing over the last 50 years. Although there are many underlying aetiologies, one of the top three causes of liver disease is non-alcoholic fatty liver disease (NAFLD), which is an ...
Mortimore, G.
core   +1 more source

Hepatic Autonomic Nervous System and Neurotrophic Factors Regulate the Pathogenesis and Progression of Non-alcoholic Fatty Liver Disease

open access: yesFrontiers in Medicine, 2020
Non-alcoholic fatty liver disease represents a continuum of excessive hepatic steatosis, inflammation and fibrosis. It is a growing epidemic in the United States of America and worldwide.
Muhammad Amir   +4 more
doaj   +1 more source

Managing alcoholic liver disease [PDF]

open access: yesClinical and Molecular Hepatology, 2015
Alcoholic liver disease continues to be a significant cause of liver-related morbidity and mortality throughout the world. A number of diagnostic and prognostic models have been developed in the management of this condition, although specific roles for ...
Vijay H. Shah
doaj   +1 more source

Associations Among Methylene Tetrahydrofolate Reductase rs1801133 C677T Gene Variant, Food Groups, and Non-alcoholic Fatty Liver Disease Risk in the Chinese Population

open access: yesFrontiers in Genetics, 2021
ObjectivesTo investigate the associations among the methylene tetrahydrofolate reductase rs1801133 C677T gene variant, food groups, and the risk of non-alcoholic fatty liver disease in the Chinese population.MethodsA study of gene polymorphism was ...
Xiaoyan Hao   +4 more
doaj   +1 more source

Dose adaptation of drugs in patients with liver disease [PDF]

open access: yes, 2009
A detailed introduction into the topic was obtained by developing a German-language online course named “Dose adjustment in Patients with Liver Disease” for the “Swiss Virtual Campus” in collaboration with PNN AG, a spin-off company of the ETH Zurich.
Schlatter-Häner, Chantal
core   +1 more source

Management of non-alcoholic fatty liver disease incidentally detected during other medical assessments

open access: yes, 2023
Elevated liver enzyme levels are a frequent incidental finding in primary care, and non-alcoholic fatty liver disease is the main cause of incidental elevation of liver enzymes worldwide.
Yeong Yeh Lee, Vincent Tee
core   +1 more source

Adipokines and redox signaling: impact on fatty liver disease. [PDF]

open access: yes, 2011
Adipokines (adipose tissue cytokines) are polypeptide factors secreted by adipose tissue in a highly regulated manner. The 'classical' adipokines (leptin, adiponectin, and resistin) are expressed only by adipocytes, but other adipokines have been shown ...
Marra, Fabio.   +2 more
core   +1 more source

Non-alcoholic fatty liver disease: Immunological mechanisms and current treatments. [PDF]

open access: yes, 2023
Non-alcoholic fatty liver disease (NAFLD) causes significant global disease burden and is a leading cause of mortality. NAFLD induces a myriad of aberrant changes in hepatocytes at both the cellular and molecular level.
Petagine, Lucy   +2 more
core   +1 more source

How big a problem is non-alcoholic fatty liver disease? [PDF]

open access: yes, 2011
This is one of a series of occasional articles that highlight areas of practice where management lacks convincing supporting ...
McPherson, Stuart   +5 more
core   +1 more source

Cystic fibrosis related chronic liver disease: a study of its influence upon prognosis and possible mechanisms for this; with specific reference to pulmonary and systemic haemodynamics [PDF]

open access: yes, 1995
MDTo assess the influence of chronic liver disease on survival a time dependent multivariate Cox regression analysis was It performed. The results confirmed that patients with evidence of chronic liver disease have a worse prognosis.
Williams, Simon Graham John
core   +4 more sources

Home - About - Disclaimer - Privacy